Advanced in Lung Metastases

Yoshihiro Kakeji

Kobe, JP 
Advanced in Lung Metastases
Kobe, JP 
OverviewLocationsClinical Research

Overview

Yoshihiro Kakeji practices in Kobe, Japan. Mr. Kakeji is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Stomach Cancer, Colorectal Cancer, Esophageal Cancer, Gastrectomy, and Endoscopy.

His clinical research consists of co-authoring 535 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Lung Metastases.

Gender
Male

Locations

Kobe, Japan
Other Locations
Tokyo, Japan
Minato, 1080073, Japan
Japan
Chuo, 6500017, Japan
Marunouchi, 1000005, Japan
Akashi, 6738558, Japan
Higashi, Japan
Fukuoka, Japan
Tanaka, 6500017, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3

535 Total Publications

A Case of Unresectable Advanced Gastric Cancer with Pathological Complete Response to SOX plus Nivolumab Therapy
A Case of Unresectable Advanced Gastric Cancer with Pathological Complete Response to SOX plus Nivolumab Therapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kakeji's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 57 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile